Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Fingolimod for multiple sclerosis: a review for the specialist nurse.
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Pharmacology of HIV integrase inhibitors.
Microglia: Architects of the Developing Nervous System.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.
Biomarkers for multiple sclerosis.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Substance Name: Riluzole
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.
Neuromyelitis Optica With Onset in Childhood and Adolescence.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
Pages
« first
‹ previous
…
161
162
163
164
165
166
167
168
169
…
next ›
last »